NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
Collegium Pharmaceutical Inc (F: 354)
354 Technical Analysis
5
As on 1st Jul 2025 354 STOCK Price closed @ 24.80 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 32.07 & Strong Sell for SHORT-TERM with Stoploss of 31.69 we also expect STOCK to react on Following IMPORTANT LEVELS. |
354STOCK Price
Open | 24.80 | Change | Price | % |
High | 24.80 | 1 Day | -0.60 | -2.36 |
Low | 24.80 | 1 Week | -0.60 | -2.36 |
Close | 24.80 | 1 Month | -1.80 | -6.77 |
Volume | 279 | 1 Year | -4.00 | -13.89 |
52 Week High 38.60 | 52 Week Low 22.00 |
F Germany Most Active Stocks
IMU | 0.10 | -99.65% |
IMU | 0.10 | -99.65% |
IMU | 0.10 | -99.65% |
IMU | 0.10 | -99.65% |
IMU | 0.10 | -99.65% |
ENB | 47.60 | -0.92% |
TEF | 3.84 | -0.52% |
TEF | 3.84 | -0.52% |
WHL | 5150.00 | -0.44% |
WDI | 0.05 | -37.50% |
F Germany Top Gainers Stocks
F Germany Top Losers Stocks
354 Daily Charts |
354 Intraday Charts |
Whats New @ Bazaartrend |
354 Free Analysis |
|
354 Important Levels Intraday
RESISTANCE | 24.80 |
RESISTANCE | 24.80 |
RESISTANCE | 24.80 |
RESISTANCE | 24.80 |
RESISTANCE | 24.80 |
RESISTANCE | 24.80 |
RESISTANCE | 24.80 |
RESISTANCE | 24.80 |
354 Forecast July 2025
4th UP Forecast | 30.2 |
3rd UP Forecast | 28.47 |
2nd UP Forecast | 27.4 |
1st UP Forecast | 26.33 |
1st DOWN Forecast | 23.27 |
2nd DOWN Forecast | 22.2 |
3rd DOWN Forecast | 21.13 |
4th DOWN Forecast | 19.4 |
354 Weekly Forecast
4th UP Forecast | 26.73 |
3rd UP Forecast | 26.11 |
2nd UP Forecast | 25.73 |
1st UP Forecast | 25.35 |
1st DOWN Forecast | 24.26 |
2nd DOWN Forecast | 23.87 |
3rd DOWN Forecast | 23.49 |
4th DOWN Forecast | 22.87 |
354 Forecast2025
4th UP Forecast | 56.79 |
3rd UP Forecast | 46.53 |
2nd UP Forecast | 40.19 |
1st UP Forecast | 33.85 |
1st DOWN Forecast | 15.75 |
2nd DOWN Forecast | 9.41 |
3rd DOWN Forecast | 3.07 |
4th DOWN Forecast | -7.19 |
Collegium Pharmaceutical Inc ( F Germany Symbol : 354 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
354 Other Details
Segment | EQ | |
Market Capital | 625935232.00 | |
Sector | Healthcare | |
Industry | Drug Manufacturers-Specialty & Generic | |
Offical website | > echo $website ; ?> |
354 Address
![]() |
354 Latest News
354 Business Profile
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts. Address: 100 Technology Center Drive, Stoughton, MA, United States, 02072
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service